Stock listing
A111X8 Stock Price, News, Filings & Events — Aldeyra Therapeutics, Inc.
Selected listing: A111X8 · LSX · EUR · DE
This page tracks Aldeyra Therapeutics, Inc.'s A111X8:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A111X8:LSX. A111X8:LSX is the stock-level entry point for investors researching Aldeyra Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A111X8:LSX
- Asset type
- Stock
- Market cap
- $72.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Aldeyra Therapeutics, Inc. A111X8:LSX stock context
This page tracks Aldeyra Therapeutics, Inc.'s A111X8:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A111X8:LSX. A111X8:LSX is the stock-level entry point for investors researching Aldeyra Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics to Host Regulatory Update Webcast
September 28, 2026
Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors
June 9, 2026
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
June 2, 2026
Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease
December 15, 2025
Aldeyra Therapeutics, Inc. earnings calls
Aldeyra Therapeutics, Inc. (ALDX) Q2 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q4 2022 Earnings Call
March 9, 2023 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q3 2022 Earnings Call
November 10, 2022 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q2 2022 Earnings Call
August 5, 2022 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q1 2022 Earnings Call
May 5, 2022 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q4 2021 Earnings Call
March 17, 2022 · Replay with transcript and chapters
Research Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A111X8:LSX.
Aldeyra Therapeutics, Inc. company profile
View the public company page for Aldeyra Therapeutics, Inc. on 6ix.
Aldeyra Therapeutics, Inc. news
Read company news and market updates connected to Aldeyra Therapeutics, Inc..
Aldeyra Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Aldeyra Therapeutics, Inc..
Alternate listings
ALDX:NASDAQ
US · USD
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is A111X8:LSX.
ALDX:BOATS
US · USD
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is A111X8:LSX.
137:GETTEX
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is A111X8:LSX.
A111X8:LS
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is A111X8:LSX.
137:FWB
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is A111X8:LSX.
137:TRADEGATE
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is A111X8:LSX.
137:DUS
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is A111X8:LSX.
137:MUN
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is A111X8:LSX.
137:SWB
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is A111X8:LSX.